Pharmacokinetics of Pavaverine After Intraluminal Administration
Information source: Johann Wolfgang Goethe University Hospitals
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Injury of Internal Mammary Artery; Complications Due to Coronary Artery Bypass Graft
Intervention: CABG (Procedure)
Phase: N/A
Status: Completed
Sponsored by: Johann Wolfgang Goethe University Hospitals Official(s) and/or principal investigator(s):
Arndt H Kiessling, MD, Principal Investigator, Affiliation: Johann Wolfgang Goethe University Hospitals
Summary
The purpose of this study is to determine the pharmacokinetic of papaverine after
administration into the artery mammaria interna.
Clinical Details
Official title: Observational Study on Papaverine During Cardiac Surgical Procedures
Study design: Observational Model: Cohort, Time Perspective: Prospective
Primary outcome: Maximum plasma concentration of papaverine
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- CABG
- Administration of papaverine into mammaria interna
Exclusion Criteria:
- Allergy against papaverine
Locations and Contacts
Klinikum der Goethe Universität Frankfurt, Frankfurt am Main, Hessen 60590, Germany
Additional Information
Starting date: October 2012
Last updated: June 3, 2013
|
